JCB, Volume 19, Number 4, 2013 From the Classroom Vol.19 No. 4 (2013) An Agile, Cross-Discipline Model for Developing Bio-Enterprise Professionals Moira A. Gunn In meeting bio-enterprise needs, university education often revolves around introducing students in the sciences to business, managerial and other professional expertise. This paper intro Intellectual Property Management Vol.19 No. 4 (2013) Competition Regulation and Recombinant Drugs in India Ravikant Bhardwaj The recombinant drug industry is growing at almost 20% rate in India. The long term growth of this sector depends upon the innovation as well as competition and market. The structure, con Case Study Vol.19 No. 4 (2013) Assessing the history and value of Human Genome Sciences Laura M. McNamee Human Genome Science (HGS) aspired to dominate the emergent field of genomics by discovering expressed gene sequences and developing therapeutic and diagnostic products based on p From the Boardroom Vol.19 No. 4 (2013) Integrated outsourcing transforms and increases R&D productivity Henry Levy Pharmaceutical companies are actively exploring new sourcing strategies to address the continuing decline in R&D productivity. Fragmented outsourcing has not sufficiently solved t Special Section Vol.19 No. 4 (2013) Unaddressed Implications of Technology in Global Health Bryan A Liang This is the introduction piece for the 9th San Diego Health Policy Conference, with papers by Tom Kubic, John Theriault, Tim Mackey, Jim Balcius, and Bryan A. Liang. Special Section Vol.19 No. 4 (2013) Technology and Global Health: Spy vs. Spy and SPOCs to Promote Global Drug Supply Safety Thomas T Kubic New anti-tampering technologies and security features along with coding of individual medicine packages can aid in identifying and then reducing harm associated with counterfeiting of med Special Section Vol.19 No. 4 (2013) Dangerous Science: Online Promotion of Unproven Stem Cell Therapies and Global Health Risks Tim Ken Mackey Stem cell-based therapies represent a potential pathway for a new era of 21st century regenerative medicine. In support of this new form of treatment, a global multibillion-dol Special Section Vol.19 No. 4 (2013) Protecting the U.S Medicine Supply: Integrating Approaches to Promote Safety John Theriault The safety and efficacy of America’s medicine supply has long been considered the “gold standard†by which other countries are measured. Our “closed systemâ� Special Section Vol.19 No. 4 (2013) Motorcycle Simulator Technology and Traffic-Related Injury Prevention: Global Health Potential James Alan Balcius Road traffic related fatalities account for over 50% of the global deaths for individuals between ages 15 and 44 and ranks 11th in the cause of death for all age groups. It’s fu Special Section Vol.19 No. 4 (2013) Technology and Medicine: Academic Dishonesty and Risks to Global Health Bryan A Liang Technology has promoted global health. Yet advancing technology has also allowed physicians and trainees to cheat, and inappropriate experimentation with medical technology has resulted i
